MDRX Sep 2024 7.500 call
| Previous close | 1.3000 |
| Open | 1.3200 |
| Bid | 0.0500 |
| Ask | 4.9000 |
| Strike | 7.50 |
| Expiry date | 2024-09-20 |
| Day's range | 1.1300 - 1.4500 |
| Contract range | N/A |
| Volume | |
| Open interest | 101 |
Business WireVeradigm Payerpath Rated Highest in Client Satisfaction
CHICAGO, May 30, 2024--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black Book Research, a healthcare-centric market research and public opinion research and consulting company, rated Veradigm Payerpath the overall number one provider of claims and clearinghouse platform solutions for small medical practices.
Business WireVeradigm Announces Leadership Updates
CHICAGO, May 28, 2024--Veradigm Inc. (OTCMKTS: MDRX, the "Company"), a leading provider of healthcare data and technology solutions, today announced that, on June 7, 2024, Tom Langan, the Company’s President and Chief Commercial Officer (CCO), will assume the role of interim Chief Executive Officer (CEO), reporting directly to the Executive Chairman and the Board. Mr. Langan has been a Company leader since 2018 and has more than 25 years of life sciences, payer and data & analytics experience. I
Business WireVeradigm to Explore Strategic Alternatives and Reaffirms 2024 Guidance
CHICAGO, May 28, 2024--Veradigm Inc. (OTCMKTS: MDRX, the "Company"), a leading provider of healthcare data and technology solutions, today announced that it has initiated a process to explore strategic alternatives to maximize shareholder value.
